Becton Dickinson expects to achieve currency-neutral revenue growth in the low single-digit range for the current fiscal year ...
In early May 2026, Becton, Dickinson and Company reported higher quarterly sales of US$4.71 billion but swung to a net loss, raised its full-year adjusted earnings guidance, completed the divestiture ...
Zacks Investment Research on MSN
BD launches Elyra thulium fiber laser system for kidney stone care
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the launch of the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform within its kidney stone care portfolio ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 second quarter, which ended March 31, 2026.
BD (Becton, Dickinson and Company) has agreed to combine its biosciences and diagnostic solutions business with Waters Corporation, creating a new life science and diagnostics company. The agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results